PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-11-09

Date Title Company
09-Nov-2020 Liminal BioSciences Announces FDA Extension of Review Period for Ryplazim®(plasminogen) BLA Liminal BioSciences Inc.
09-Nov-2020 Inmagene Biopharmaceuticals closed $21 million Series B financing, making the total raised to date over $40 million Inmagene Biopharmaceuticals